From research & product development to market uptake within the diagnostics sector

Online Seminar

21 April 2022 - 21 April 2022

From research & product development to market uptake within the diagnostics sector

The recent Corona pandemic taught us the importance of getting new diagnostics to market rapidly for keeping public life and the economy running. Join this online seminar to gain a clear overview of how to navigate from the development of your diagnostic, through intellectual property and financing issues, to market access. Meet our experts face-to-face to get tailored support for your diagnostic product.

This event is part of the Interreg NWE project Codex4SMEs which aims to support SMEs along the full diagnostics development value chain.


Date:                  April 21st, 2022 at 13:00 – 15:00 CEST


13:00 – 13:10 Codex4SMEs – a support network for SMEs
13:10 – 13:30

A brief guide to patenting diagnostic inventions

by René Raggers | European Patent Attorney / Partner at AOMB Intellectual Property – an expert within the EATRIS network

  • What is possible in Europe?
  • What in the USA?
  • Brief remarks on strategy, Dos and Don’ts
13:30 – 13:50

Requirements for SMEs from the perspective of investors: Seven habits of highly effective biomarkers

by Wim Van Criekinge – Founding partner at the Novalis Biotech Acceleration Fund, and professor computational genomics and bioinformatics at the Ghent University

13:50 – 14:10

Regulatory and Quality Compliance requirements to access the EU Diagnostics Market 

by Greer Deal | Director at Med-Di-Dia – an expert within the Codex4SMEs Business Growth Programme

  • An overview of how to develop a regulatory and quality compliance strategy to enter the EU market
  • The impact of changing regulatory requirements in the EU for the In-Vitro Diagnostics Industry
  • How a structured approach to quality requirements is the foundation for success in Europe and beyond
14:10 – 14:15 Q&A
14:15 – 15:00 One-to-one meetings via virtual matchmaking platform



Share this

Tweet Share